Weight control – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:15:05 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Weight control – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Study on Petrelintide for Weight Loss in Overweight or Obese Patients with Related Health Issues https://clinicaltrials.eu/trial/study-on-petrelintide-for-weight-loss-in-overweight-or-obese-patients-with-related-health-issues/ Wed, 29 Apr 2026 15:03:51 +0000 https://clinicaltrials.eu/trial/study-on-petrelintide-for-weight-loss-in-overweight-or-obese-patients-with-related-health-issues/ This clinical trial is focused on studying the effects of a new treatment called Petrelintide for individuals who are obese or overweight and have related health issues. The treatment involves a solution for injection that is administered under the skin. The study will compare the effects of different doses of Petrelintide to a placebo, which is a substance with no active medication, to see how they affect body weight when combined with a reduced-calorie diet and increased physical activity.

The main goal of the study is to understand how different doses of Petrelintide can help reduce body weight over a period of 28 weeks. Participants will receive injections once a week and will be monitored to see how their body weight changes. The study will also look at whether participants can achieve a weight loss of 5% or 10% from their starting weight by the end of the study period.

This trial is designed to help researchers find the most effective dose of Petrelintide for managing weight in people with obesity or overweight conditions. Participants will be asked to follow a specific diet and exercise plan while receiving the treatment. The study aims to provide valuable information on how Petrelintide can be used as a part of a weight management program.

]]>